|
|
|
Company
Name |
Short
Summary |
| Abbott Laboratories |
Abbott
Labs is a biotech company with a wide range of pharmaceutical
and diagnostic products. Abbott has thier vascular devices unit in Redwood City. |
| AcelRx Pharmaceuticals |
AcelRx Pharmaceuticals is focused on the development and commercialization of therapies for the treatment of acute and breakthrough pain. |
| AP Pharma |
AP Pharma is focused on the research and development of products using their proprietary Biochronomer™ polymer-based drug delivery technology. |
| Cardica |
Cardica is focused on the development and commercialization of stapling devices for surgical procedures. |
| Codexis |
Codexis is focused on the develompent and commercialization of industrial biocatalysts, enzymes, and microbes for the energy, pharmaceutical, and environmental industries. |
| Coherus Biosciences |
Coherus Biosciences is focused on the development and commercialization of biosimilar therapies. |
| Facet Biotech |
Facet Biotech is focused on monoclonal antibody development to treat cancer and immunological diseases. |
| Genomic Health |
Genomic Health is focused on the research, development, and commercialization of genomic based clinical laboratory services. |
| InGenuity
Systems |
InGenuity™
was founded in 1998 with the goal of developing
an innovative knowledge management tool that would
provide timely access to relevant biological data
and thus enable the life science researchers to
make Better Decisions Faster™. |
| Maxygen |
Maxygen
is the leader in the emerging field of directed
molecular evolution, a process by which novel
genes are generated for commercial use. |
| OncoMed Pharmaceuticals |
OncoMed Pharmaceuticals is focused on developing monoclonal antibodies that target cancer stem cells. |
| Pathwork Diagnostics |
Pathwork Diagnostics is focused on the development and commercialization of microarray based expression tests for oncology. |
| Pearl Therapeutics |
Pearl Therapeutics is focused on developing combination therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and other chronic respiratory diseases. |
| ReGen Biologics |
ReGen Biologics is focused on the development and commercialization of tissue implants to replace damaged or removed soft tissue. |
| Threshold Pharmaceuticals |
Threshold Pharmaceuticals is focused on small molecule drugs that take advantage of tumor hypoxia. |
| Valeant
Pharmaceuticals |
Valeant
Pharmaceuticals is invovled in the discovery, development,
and commercialization of products primarily focused
in infectious disease, neurology, and dermatology. |
